13F-HR filed by NOVO HOLDINGS A/S
NOVO HOLDINGS A/S filed this 13F-HR for the quarter ended 2021-12-31, filed 2022-02-14, with 48 holding rows worth $2,111,972,000.
- Accession
- 0000950123-22-002394
- Filer
- CIK 1388325
- Filed
- 2022-02-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2021
A holdings report, 48 entries on the cover page, a total value of $2,111,972,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,111,971,000 with VALUE read as thousands by filing date, 13F file number 028-16231. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| VTI | 922908769 | COM | 1,933,900 | $466,921,000 | thousands by filing date | |
| EXSCIENTIA PLC | 30223G102 | ADS | 13,086,600 | $258,591,000 | thousands by filing date | |
| BROOKFIELD ASSET MANAGEMENT IN | 112585104 | CL A LTD VT SH | 2,921,171 | $176,380,000 | thousands by filing date | |
| Apple Inc | 037833100 | COM | 918,879 | $163,165,000 | thousands by filing date | |
| Boston Scientific Corporation | 101137107 | COM | 3,463,577 | $147,133,000 | thousands by filing date | |
| MORPHIC HLDG INC | 61775R105 | COM | 2,050,446 | $97,150,000 | thousands by filing date | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 5,587,207 | $85,373,000 | thousands by filing date | |
| ALIBABA GROUP HLDG LTD | 01609W102 | SPONSORED ADS | 500,827 | $59,493,000 | thousands by filing date | |
| CYTEIR THERAPEUTICS INC | 23284P103 | COMMON | 4,840,413 | $55,035,000 | thousands by filing date | |
| NKARTA INC | 65487U108 | COMMON STOCK | 2,793,864 | $42,886,000 | thousands by filing date | |
| MIRUM PHARMACEUTICALS INC | 604749101 | COM | 2,445,147 | $39,000,000 | thousands by filing date | |
| INOGEN INC | 45780L104 | COM | 1,072,735 | $36,473,000 | thousands by filing date | |
| ALIGOS THERAPEUTICS INC COM NEW | 01626L105 | Stock | 2,614,563 | $31,035,000 | thousands by filing date | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 2,560,211 | $29,570,000 | thousands by filing date | |
| RENEO PHARMACEUTICALS INC | 75974E103 | COM | 3,430,377 | $29,330,000 | thousands by filing date | |
| CABLE ONE INC | 12685J105 | COM | 15,873 | $27,991,000 | thousands by filing date | |
| VERVE THERAPEUTICS INC | 92539P101 | COM | 700,000 | $25,809,000 | thousands by filing date | |
| BOLT BIOTHERAPEUTICS INC | 097702104 | COM | 4,503,991 | $22,070,000 | thousands by filing date | |
| BLUEPRINT MEDICINES CORP | 09627Y109 | COM | 197,000 | $21,101,000 | thousands by filing date | |
| IO BIOTECH INC | 449778109 | COM | 3,277,932 | $20,979,000 | thousands by filing date | |
| SPRUCE BIOSCIENCES INC | 85209E109 | COM | 4,514,336 | $20,134,000 | thousands by filing date | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 695,840 | $18,955,000 | thousands by filing date | |
| LAVA THERAPEUTICS NV | N51517105 | SHS | 3,327,312 | $18,300,000 | thousands by filing date | |
| VECTIVBIO HLDG AG | H9060V101 | COM | 3,522,019 | $17,293,000 | thousands by filing date | |
| Milestone Pharmaceuticals Inc | 59935V107 | COM | 2,530,585 | $16,575,000 | thousands by filing date | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 836,518 | $15,969,000 | thousands by filing date | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 612,822 | $13,378,000 | thousands by filing date | |
| SEASPINE HLDGS CORP | 81255T108 | COM | 858,752 | $11,696,000 | thousands by filing date | |
| GALERA THERAPEUTICS EQUICLASS EQUITY | 36338D108 | COMMON STOCK | 2,459,021 | $11,287,000 | thousands by filing date | |
| MINERVA SURGICAL INC | 60343F106 | COM | 2,057,132 | $10,574,000 | thousands by filing date | |
| KINNATE BIOPHARMA INC | 49705R105 | COM | 553,128 | $9,801,000 | thousands by filing date | |
| TREACE MED CONCEPTS INC | 89455T109 | COM | 500,421 | $9,328,000 | thousands by filing date | |
| AKOUOS INC | 00973J101 | COM | 1,061,990 | $9,027,000 | thousands by filing date | |
| INSPIRE MED SYS INC COM | 457730109 | Stock | 35,500 | $8,167,000 | thousands by filing date | |
| PULMONX CORP | 745848101 | COM | 247,047 | $7,923,000 | thousands by filing date | |
| MARQETA INC | 57142B104 | CLASS A COM | 441,558 | $7,582,000 | thousands by filing date | |
| GALECTO INC | 36322Q107 | COM | 2,497,791 | $7,568,000 | thousands by filing date | |
| SPERO THERAPEUTICS INC | 84833T103 | COM | 468,902 | $7,507,000 | thousands by filing date | |
| PHARVARIS NV | N69605108 | COMMON STOCK | 516,321 | $7,430,000 | thousands by filing date | |
| ZOGENIX INC. | 98978L204 | Common Stock | 442,550 | $7,191,000 | thousands by filing date | |
| INARI MED INC | 45332Y109 | COM | 72,212 | $6,591,000 | thousands by filing date | |
| SILK ROAD MEDICAL INC | 82710M100 | COMMON STOCK | 147,557 | $6,287,000 | thousands by filing date | |
| CHECKMATE PHARMACEUTICALS IN | 162818108 | COM | 2,170,100 | $6,228,000 | thousands by filing date | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 761,205 | $5,115,000 | thousands by filing date | |
| PRAXIS PRECISION MEDICINES I | 74006W108 | COM | 250,000 | $4,925,000 | thousands by filing date | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 25,000 | $4,240,000 | thousands by filing date | |
| AERIE PHARMACEUTICALS INC | 00771V108 | COM | 555,186 | $3,897,000 | thousands by filing date | |
| FREELINE THERAPEUTICS HLDGS | 35655L107 | SPONSORED ADS | 1,776,613 | $3,518,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000950123-22-002394 | this filing | 2022-02-14 | acceptance time not in the bulk data set |